Best in Biotech 13 Mar 2025
Nine biotechs thriving in Seattle in 2025
…its candidate came to light. Its investigational drug is being tested to treat hepatitis B (HBV) infections. TUNE-401 utilizes Tune’s epigenetics platform TEMPO to epigenetically silence viral HBV DNA in…